Douglas Pagán
Direttore Finanziario/CFO presso Jnana Therapeutics, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Joanne Kotz | M | - |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 7 anni |
| Theo Melas-Kyriazi | M | 64 |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | 5 anni |
| Jonathan Light | M | - | 7 anni | |
| Stephen Pacala | M | 67 |
Princeton University
| 32 anni |
| Stuart Schreiber | M | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 7 anni |
| Carlo Rizzuto | M | 53 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Nick Pullen | M | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Morris Loeb | M | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Brian Danieli | M | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 3 anni |
| Ronald Renaud | M | 55 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Ramnik Xavier | M | 62 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 7 anni |
| Matthew Hammond | M | 35 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Elaine Jones | M | 69 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Brian M. Cali | M | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 6 anni |
| Annie C. Chen | M | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 3 anni |
| Kevin Kinsella | M | 78 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Randy Brenner | M | 51 | 9 anni | |
| Donald Nicholson | M | 67 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 5 anni |
| Cecilia Elena Rouse | M | 60 |
Princeton University
| 32 anni |
| Margarita I. Chavez | F | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Raj Padmanabhan | M | - | 9 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| David Mauney | M | 56 | 3 anni | |
| Adam Veness | M | 38 | 7 anni | |
| Heidi Hagen | F | 55 | 2 anni | |
| William Haskel | M | 63 | - | |
| Kevin A. Davis | M | - |
Princeton University
| 4 anni |
| Debra Perelman | F | 50 |
Columbia Business School
Princeton University
| 7 anni |
| Benjamin J. Strain | M | - | 3 anni | |
| Arif Padaria | M | - |
Columbia Business School
Princeton University
| 4 anni |
| Wyche Fowler | M | 83 | 13 anni | |
| George Golumbeski | M | 67 | 7 anni | |
| Kristine Peterson | F | 64 | 7 anni | |
| John W. James | M | - |
Columbia Business School
Princeton University
| 6 anni |
| Geoffrey Rubin | M | - |
Princeton University
| 6 anni |
| Robert D. Stock | M | - |
Princeton University
| 4 anni |
| Christopher Bowden | M | 63 | 4 anni | |
| Randal Kirk | M | 70 | 7 anni | |
| John R. Weber | M | - |
Columbia Business School
Princeton University
| 7 anni |
| Francois Lebel | M | 72 | 5 anni | |
| Judith N. Steenbergen | M | - | - | |
| Christine Coyne | F | 55 | 4 anni | |
| Sanjay Kumar Sanghoee | M | - |
Columbia Business School
| 2 anni |
| Christopher Taylor | M | - | - | |
| Debra Perelman | F | - |
Columbia Business School
Princeton University
| 7 anni |
| Li Zhong Dai | M | 56 |
Princeton University
| 5 anni |
| Prakash Raman | M | 54 |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | - |
| Scott Koenig | M | - |
Columbia Business School
Princeton University
| 7 anni |
| Marc Conner | M | - |
Princeton University
| 4 anni |
| Jolie von Arnim | F | - |
Columbia Business School
Princeton University
| 7 anni |
| Wendy Young | M | - |
Princeton University
| 4 anni |
| Timothy Franson | M | 72 | 8 anni | |
| Drew Deniger | M | 44 | 4 anni | |
| Richard Lim | M | 52 | 4 anni | |
| Christoph Westphal | M | 56 | 10 anni | |
| Joseph Zakrzewski | M | 60 | 10 anni | |
| Jasbir Seehra | M | 68 | 6 anni | |
| Elan Ezickson | M | 60 | 2 anni | |
| Giorgio Caputo | M | 50 |
Columbia Business School
Princeton University
| 7 anni |
| Peter C. M. McWilliams | M | - |
Princeton University
| 3 anni |
| Zuie Chin Huang | M | 59 | 3 anni | |
| Terrence Kearney | M | 69 | 7 anni | |
| Sarah Higgins | F | 48 | - | |
| Peter Rathjens | M | 65 |
Princeton University
| 4 anni |
| Anthony Evnin | M | 83 | 10 anni | |
| Wylie W. Vale | M | 82 | 9 anni | |
| Kevin McLaughlin | M | 67 | 11 anni | |
| James Cannon | M | 85 | 14 anni | |
| Murray Brennan | M | 84 | 13 anni | |
| Vassilios Niko Nicopoulos | M | - |
Princeton University
| 5 anni |
| Jonathan A. G. Auerbach | M | 50 |
Columbia Business School
Princeton University
| 8 anni |
| Rolf K. Hoffmann | M | 64 | 5 anni | |
| Frank Mora | M | - |
Columbia Business School
| 2 anni |
| Daniel Von Kohorn | M | - |
Princeton University
| 4 anni |
| Stephen Lionel Prince | M | 50 |
Princeton University
| 4 anni |
| Matt Drapkin | M | 50 |
Princeton University
| 4 anni |
| Philip Dur | M | 51 |
Princeton University
| 4 anni |
| Meerie M. Joung | F | - |
Princeton University
| 4 anni |
| Sean Uberoi Kelly | M | - |
Princeton University
| 4 anni |
| Peter B. Kellner | M | 54 |
Princeton University
| 4 anni |
| Clifford A. Smith | M | - |
Princeton University
| 1 anni |
| Erik J. Schneider | M | - |
Princeton University
| 4 anni |
| Andrew Hayden O'Brien | M | - |
Princeton University
| 4 anni |
| Craig Leighton | M | - |
Princeton University
| 1 anni |
| Kevin Kavanagh | M | - |
Princeton University
| 4 anni |
| Mark J. Birmingham | M | - |
Princeton University
| 4 anni |
| Jason Todd | M | - |
Princeton University
| 4 anni |
| Rafael Edward Cruz | M | 53 |
Princeton University
| 4 anni |
| Stewart L. McDowell | F | - |
Princeton University
| 4 anni |
| Scott D. Karchmer | M | - |
Princeton University
| 4 anni |
| Ashlee Bryan Patten | F | - |
Princeton University
| 4 anni |
| Ken J. Ruskin | M | - |
Princeton University
| 4 anni |
| Paul Caminiti | M | - |
Princeton University
| 4 anni |
| George Bumeder | M | 54 |
Princeton University
| 4 anni |
| Cameron Scholvin | M | - |
Princeton University
| 4 anni |
| David Bros | M | - |
Princeton University
| 4 anni |
| Jason Kamras | M | - |
Princeton University
| 4 anni |
| John Kole | M | - |
Princeton University
| 4 anni |
| Peter W. Sloan | M | - |
Princeton University
| 4 anni |
| Jian Ping Mei | M | 63 |
Princeton University
| 4 anni |
| Tim Gong | M | 60 |
Princeton University
| 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Douglas Pagán
- Contatti personali
